Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMelrose Regulatory News (MRO)

Share Price Information for Melrose (MRO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 640.40
Bid: 639.40
Ask: 639.80
Change: 15.20 (2.43%)
Spread: 0.40 (0.063%)
Open: 628.40
High: 640.80
Low: 626.60
Prev. Close: 625.20
MRO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Melrose Industries PLC

26 Feb 2018 07:00

RNS Number : 8518F
Empyrean Capital Partners, LP
23 February 2018
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Empyrean Capital Partners, LP

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Melrose Industries plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

February 23, 2018

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

Yes - GKN plc

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

48/7p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

(2) Cash-settled derivatives:

 

13,822,998

0.71%

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

13,822,998

0.71%

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

48/7p ordinary

Total return swap

 

Decreasing a short position

250,000

2.2714

48/7p ordinary

Total return swap

 

Decreasing a short position

250,000

2.2712

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

February 23, 2018

Contact name:

Tanaz F. Dietz

Telephone number:

310.843.3061

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETTJMTTMBJTTAP
Date   Source Headline
24th Jun 20213:44 pmRNSDirector/PDMR Shareholding
22nd Jun 20213:31 pmRNSPosting of Circular and Notice of General Meeting
22nd Jun 20217:00 amRNSAir Management Disposal and Return of Capital
28th May 20214:00 pmRNSDirector/PDMR Shareholding
19th May 20214:48 pmRNSCapital Markets Event
6th May 20211:45 pmRNSResults of GM and AGM
6th May 20217:00 amRNSTrading Statement AGM
20th Apr 20213:34 pmRNSPosting of Circular and Notice of General Meeting
19th Apr 20217:00 amRNSProposed Disposal of Nortek Air Management
9th Apr 20217:00 amRNSAppointment of Non-Executive Directors
31st Mar 20214:30 pmRNSAnnual Financial Report
26th Mar 20215:00 pmRNSStandard annual confirmation of POUs
4th Mar 20214:04 pmRNSDirector/PDMR Shareholding
4th Mar 20217:00 amRNSFinal Results
21st Jan 20214:45 pmRNSResult of Meeting
4th Jan 20217:00 amRNSAppointment of Executive Director
29th Dec 202012:30 pmRNSPosting of Circular and Notice of General Meeting
8th Dec 20204:05 pmRNSHolding(s) in Company
25th Nov 20207:00 amRNSTrading Statement
25th Sep 20209:51 amRNSDirector/PDMR Shareholding
3rd Sep 20207:00 amRNSHalf-year Report
4th Aug 20207:00 amRNSFinancing Update
22nd Jul 20207:00 amRNSTrading Statement
4th Jun 20202:36 pmRNSDirector/PDMR Shareholding
28th May 20207:00 amRNSDirector/PDMR Shareholding
14th May 20207:00 amRNSDirector/PDMR Shareholding
7th May 202012:56 pmRNSResult of AGM
7th May 20207:00 amRNSTrading Statement
6th May 20204:56 pmRNSHolding(s) in Company - Replacement
5th May 20204:10 pmRNSHolding(s) in Company
5th May 20204:09 pmRNSHolding(s) in Company
4th May 20207:00 amRNSHolding(s) in Company
1st May 20205:05 pmRNSHolding(s) in Company
28th Apr 20205:02 pmRNSRegulatory Filing – LR.9.2.6E
15th Apr 202011:03 amRNSHolding(s) in Company
14th Apr 20207:00 amRNSHolding(s) in Company
3rd Apr 202011:04 amRNSAnnual Report and Notice of AGM
31st Mar 20209:57 amRNSStandard annual confirmation of POUs
30th Mar 20204:25 pmRNSTrading Statement
19th Mar 20209:42 amRNSHolding(s) in Company
16th Mar 20207:00 amRNSDirector/PDMR Shareholding
13th Mar 20203:33 pmRNSHolding(s) in Company
10th Mar 20209:46 amRNSDirector/PDMR Shareholding
9th Mar 202011:13 amRNSDirector/PDMR Shareholding
9th Mar 20207:00 amRNSDirector/PDMR Shareholding
5th Mar 20207:00 amRNSFinal Results
19th Nov 20197:00 amRNSTrading Statement
18th Oct 20194:30 pmRNSDirector/PDMR Shareholding
1st Oct 20197:00 amRNSAppointment of Independent Non-Executive Director
5th Sep 20197:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.